Chemically induced mouse models of colitis

Current Protocols in Pharmacology

Volumn , Issue SUPPL. 46, 2009, Pages

  Waldner, Maximilian J ^a,b   Neurath, Markus F ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Animal; Colitis; Dextran sulfate; Disease models; Inflammatory bowel disease; Mice; Trinitrobenzenesulfonic acid

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CYCLOSPORIN; DEXTRAN SULFATE; OXAZOLONE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

CHEMICALLY INDUCED DISORDER; COLITIS; COLON CROHN DISEASE; DISEASE MODEL; ENTERITIS; EXPERIMENTAL MOUSE; HISTOPATHOLOGY; IMMUNOREACTIVITY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

ANIMAL HUSBANDRY; ANIMALS; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; MICE; OXAZOLONE; TRINITROBENZENESULFONIC ACID;

EID: 70149095937     PISSN: 19348282     EISSN: 19348290     Source Type: Journal    
DOI: 10.1002/0471141755.ph0555s46     Document Type: Review

References (22)

1. Becker, C., Fantini, M.C., Wirtz, S., Nikolaev, A., Kiesslich, R., Lehr, H.A., Galle, P.R., and Neurath, M.F. 2005. In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut 54:950-954.
2. Becker,C., Dornhoff, H., Neufert,C., Fantini, M.C., Wirtz, S., Huebner, S., Nikolaev, A., Lehr, H.A., Murphy, A.J., Valenzuela, D.M., Yancopoulos, G.D., Galle, P.R., Karow,M., and Neurath,M.F. 2006. Cutting edge: IL-23 cross-regulates IL- 12 production in T cell-dependent experimental colitis. J. Immunol. 177:2760-2764.
3. Boirivant, M., Fuss, I.J., Chu, A., and Strober, W. 1998. Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J. Exp. Med. 188:1929-1939.
4. Dieleman, L.A., Ridwan, B.U., Tennyson, G.S., Beagley, K.W., Bucy, R.P., and Elson, C.O. 1994. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107:1643-1652.
5. Dieleman, L.A., Palmen,M.J., Akol, H., Bloemena, E., Peña, A.S., Meuwissen, S.G., and Van Rees, E.P. 1998. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin. Exp. Immunol. 114:385-391.
6. Donovan, J. and Brown, P. 2006. Euthanasia. Curr. Protoc. Immunol. 73:1.8.1-1.8.4.
7. Ekström, G.M. 1998. Oxazolone-induced colitis in rats: Effects of budesonide, cyclosporin A, and 5-aminosalicylic acid. Scand. J. Gastroenterol. 33:174-179.
8. Fichtner-Feigl, S., Fuss, I.J., Preiss, J.C., Strober, W., and Kitani, A. 2005. Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides. J. Clin. Invest. 115:3057-3071.
9. Heller, F., Fuss, I.J., Nieuwenhuis, E.E., Blumberg, R.S., and Strober, W. 2002. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17:629-638.
10. Heller, F., Florian, P., Bojarski, C., Richter, J., Christ, M., Hillenbrand, B., Mankertz, J., Gitter, A.H., Bürgel, N., Fromm, M., Zeitz, M., Fuss, I., Strober, W., and Schulzke, J.D. 2005. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129:550-564.
11. Morris, G.P., Beck, P.L., Herridge, M.S., Depew, W.T., Szewczuk, M.R., and Wallace, J.L. 1989. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795-803.
12. Mudter, J., Amoussina, L., Schenk, M., Yu, J., Brüstle, A., Weigmann, B., Atreya, R., Wirtz, S., Becker, C., Hoffman, A., Atreya, I., Bi esterfeld, S., Galle, P.R., Lehr, H.A., Rose- John, S., Mueller, C., Lohoff, M., and Neurath, M. 2008. The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6. J. Clin. Invest. 118:2415-2426.
13. Murthy, S.N., Cooper, H.S., Shim, H., Shah, R.S., Ibrahim, S.A., and Sedergran, D.J. 1993. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig. Dis. Sci. 38:1722-1734.
14. Myers, K.J., Murthy, S., Flanigan, A., Witchell, D.R., Butler, M., Murray, S., Siwkowski, A., Goodfellow, D., Madsen, K., and Baker, B. 2003. Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis. J. Pharmacol. Exp. Ther. 304:411-424.
15. Neurath, M.F., Fuss, I., Kelsall, B.L., Stüber, E., and Strober, W. 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182:1281-1290.
16. Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y., and Nakaya, R. 1990. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98:694-702.
17. Pantzar, N., Ekström, G.M., Wang, Q., and Weström, B.R. 1994. Mechanisms of increased intestinal [51Cr]EDTA absorption during experimental colitis in the rat. Dig. Dis. Sci. 39:2327-2333.
18. Sartor, R.B. 2006. Mechanisms of disease: Pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3:390-407.
19. Shen, C., de Hertogh, G., Bullens, D.M., Van Assche, G., Geboes, K., Rutgeerts, P., and Ceuppens, J.L. 2007. Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis: Mechanisms beyond neutralization? Inflamm. Bowel Dis. 13:308-316.
20. Strober, W., Fuss, I.J., and Blumberg, R.S. 2002. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20:495-549.
21. Wirtz, S. and Neurath, M.F. 2007. Mouse models of inflammatory bowel disease. Adv. Drug Deliv. Rev. 59:1073-1083.
22. Xavier, R.J. and Podolsky, D.K. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427-434.